Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $150000.0.

  • Onconetix's Other Non-Current Assets fell 5902.9% to $150000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $150000.0, marking a year-over-year decrease of 5902.9%. This contributed to the annual value of $300000.0 for FY2024, which is 1805.81% down from last year.
  • Latest data reveals that Onconetix reported Other Non-Current Assets of $150000.0 as of Q3 2025, which was down 5902.9% from $300000.0 recorded in Q4 2024.
  • In the past 5 years, Onconetix's Other Non-Current Assets registered a high of $21.3 million during Q1 2023, and its lowest value of $150000.0 during Q3 2025.
  • For the 3-year period, Onconetix's Other Non-Current Assets averaged around $2.7 million, with its median value being $366113.0 (2023).
  • Over the last 5 years, Onconetix's Other Non-Current Assets had its largest YoY gain of 0.0% in 2024, and its largest YoY loss of 9827.76% in 2024.
  • Over the past 3 years, Onconetix's Other Non-Current Assets (Quarter) stood at $366113.0 in 2023, then fell by 18.06% to $300000.0 in 2024, then tumbled by 50.0% to $150000.0 in 2025.
  • Its Other Non-Current Assets was $150000.0 in Q3 2025, compared to $300000.0 in Q4 2024 and $366113.0 in Q3 2024.